Internal Medicine, Addiction Medicine · Beverly Hills, CA
NPI
1922157320
Since 2007
Specialty
Internal Medicine, Addiction Medicine
Code 207RA0401X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
8484 Wilshire Blvd, Suite 200
Beverly Hills, CA, 90211
Phone (310) 360-7690
Groups this clinician bills Medicare through
Medicare paid, 2024
$319K
7,000 services
Medicare patients, 2024
180
Average age 63
Drug cost, 2024
$2.8M
3,733 prescriptions
Company payments, 2025
$1,525
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan Reitman was code 99233 (hospital e&m - subsequent), 455 times for 104 patients. In total Jonathan Reitman billed 7,000 services in 37 codes, and Medicare paid $319K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 455 | 104 | $98.39 | $45K |
| 99213 Office E&M - Established | Office | 455 | 79 | $73.07 | $33K |
| 99232 Hospital E&M - Subsequent | Facility | 275 | 71 | $65.58 | $18K |
| 99223 Hospital E&M - Initial | Facility | 165 | 102 | $133.07 | $22K |
| 99238 Hospital Discharge Management | Facility | 141 | 86 | $68.53 | $9,663 |
| 99231 Hospital E&M - Subsequent | Facility | 108 | 26 | $39.69 | $4,287 |
| 90836 Psychotherapy - Nongroup | Office | 44 | 17 | $68.85 | $3,029 |
By year: 2022 $324K for 7,667 services; 2023 $296K for 6,603 services; 2024 $319K for 7,000 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 25 | 17 | $2.95 | $73.83 |
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan Reitman prescribed most often to Medicare patients was Buprenorphine Hcl, with 176 prescriptions and refills. In total Jonathan Reitman wrote 3,733 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine Hcl Generic | 176 | 188 | 25 | $6,353 |
| Gabapentin Generic | 155 | 194 | 42 | $2,320 |
| Oxycodone Hcl Generic | 119 | 143 | 12 | $8,184 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 109 | 115 | 30 | $21K |
| Diazepam Generic | 105 | 112 | 18 | $620 |
| Atorvastatin Calcium Generic | 90 | 150 | 20 | $604 |
| Trazodone Hcl Generic | 81 | 137 | 24 | $803 |
| Tamsulosin Hcl Generic | 72 | 95 | 11 | $628 |
| Serostim Somatropin | 71 | 82 | Under 11 | $1.7M |
| Lorazepam Generic | 70 | 70 | 13 | $754 |
| Quetiapine Fumarate Generic | 67 | 97 | 16 | $896 |
| Levothyroxine Sodium Generic | 62 | 94 | 11 | $1,398 |
| Tramadol Hcl Generic | 59 | 59 | Under 11 | $974 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 58 | 58 | Under 11 | $237K |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 54 | 54 | Under 11 | $40K |
Brand drugs: 666 claims; generic drugs: 3,036 claims; opioid claims: 329.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan Reitman $1,525 ($1,525 in general payments such as food, travel and fees) from 13 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $378.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 13 | $378 |
| Indivior Inc. INDV | 8 | $239 |
| Abbvie Inc. ABBV | 8 | $232 |
| ViiV Healthcare Company GSK | 7 | $202 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $96.22 |
| Gilead Sciences, Inc. GILD | 2 | $64.49 |
| EMD Serono, Inc. MRK.DE | 2 | $54.81 |
| Amgen Inc. AMGN | 2 | $44.2 |
| Merck Sharp & Dohme LLC MRK | 1 | $26.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.